Abstract
FAT10, as a small ubiquitin-like modifier, plays an important role in various cellular processes, including mitosis, immune response, and apoptosis, the dys-regulation of which may arise tumorigenesis. Therefore, the aim of this study was to examine the expression of FAT10 at gene and protein levels in glioma samples with different WHO grades and its association with survival. One hundred and twenty-eight glioma specimens and 10 non-neoplastic brain tissues were collected. Immunohistochemistry assay, quantitative real-time PCR and Western blot analysis were carried out to investigate the expression of FAT10. Kaplan-Meier method and Cox’s proportional hazards model were used in survival analysis. Immunohistochemistry showed that FAT10 protein was over-expressed in glioma tissues. FAT10 mRNA and protein levels were both higher in glioma compared to control on real-time PCR and Western blot analysis (both P < 0.001). Additionally, its expression levels increase from grade I to grade IV glioma according to the results of real-time PCR, immunohistochemistry analysis and Western blot. Moreover, the survival rate of FAT10-positive patients was significantly lower than that of FAT10-negative patients (P < 0.001). We further confirmed that the increased expression of FAT10 was a significant and independent prognostic indicator in glioma by multivariate analysis (P < 0.001). Our data provides convincing evidence for the first time that the increased expression of FAT10 at gene and protein levels is correlated with poor outcome in patients with glioma. FAT10 may promote the aggressiveness of glioma and may be a potential prognosis predictor of glioma.
Similar content being viewed by others
References
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93
Louis DN, Ohgaki H, Wiestler OD (2007) The 2007 WHO classifcation of tumors of the central nervous system. Acta Neuropathol 114:97–109
Mu YG, Chen MZ, Chen ZP, Zhou WN, Zhang XH, Sai K (2004) Microsurgical technique of brain glioma—a report of 183 cases. Ai Zheng 23:1317–1321
Chang CY, Li MC, Liao SL, Huang YL, Shen CC, Pan HC (2005) Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12:930–933
Lin H, Wang Y, Zhang X, Liu B, Zhang W, Cheng J (2011) Prognostic significance of kappaB-Ras1 expression in gliomas. Med Oncol In press
Jentsch S, Pyrowolakis G (2000) Ubiquitin and its kin: how close are the family ties? Trends Cell Biol 10:335–342
Li T, Santockyte R, Yu S, Shen RF, Tekle E, Lee CG, Yang DC, Chock PB (2011) FAT10 modifies p53 and upregulates its transcriptional activity. Arch Biochem Biophys 509:164–169
Canaan A, Yu X, Booth CJ, Lian J, Lazar I, Gamfi SL, Castille K, Kohya N, Nakayama Y, Liu YC, Eynon E, Flavell R, Weissman SM (2006) FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 26:5180–5189
Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G (2005) FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol 25:3483–3491
Raasi S, Schmidtke G, Groettrup M (2001) The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem 276:35334–35343
Ji F, Jin X, Jiao CH, Xu QW, Wang ZW, Chen YL (2009) FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging. World J Gastroenterol 15:2228–2233
Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K, Groettrup M (2008) Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27:6068–6074
Qing X, French BA, Oliva J, French SW (2011) Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms. Exp Mol Pathol 90:51–54
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, Choti M, Lee LA (2003) Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22:2592–2603
Brown RS, Wahl RL (1993) Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study. Cancer 72:2979–2985
Ren J, Wang Y, Gao Y, Mehta SB, Lee CG (2011) FAT10 mediates the effect of TNF-α in inducing chromosomal instability. J Cell Sci 124:3665–3675
Zhang DW, Jeang KT, Lee CG (2006) p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 25:2318–2327
Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL, Lee CG (2006) FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem 281:11413–11421
Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR, Weissman SM (1999) A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci U S A 96:4313–4318
Acknowledgments
This work was funded by Natural Science Foundation of China (NO. 81101736).
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Jun Yuan and Yanyang Tu offer the equal contributions to this paper.
Rights and permissions
About this article
Cite this article
Yuan, J., Tu, Y., Mao, X. et al. Increased Expression of FAT10 is Correlated with Progression and Prognosis of Human Glioma. Pathol. Oncol. Res. 18, 833–839 (2012). https://doi.org/10.1007/s12253-012-9511-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-012-9511-2